MAPK1 and Alzheimer disease: Additionally, the top upstream kinases, HIPK2, MAPK1, MAPK8, MAPK3, and TAF1, targeted 21, 41, 24, 32, 13, and 8 DEGs (P < 0.01), respectively, in elderly individuals with AD (Fig. 8B).